143 related articles for article (PubMed ID: 25754587)
1. Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles.
Zhang H; Ji Y; Chen Q; Jiao X; Hou L; Zhu X; Zhang Z
J Drug Target; 2015; 23(6):552-67. PubMed ID: 25754587
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-mediated fullerenes nanoparticles as Fe(2+)-dependent drug vehicles for synergistic anti-tumor efficacy.
Zhang H; Hou L; Jiao X; Ji Y; Zhu X; Zhang Z
Biomaterials; 2015 Jan; 37():353-66. PubMed ID: 25453964
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Efficacy of Artemisinin Loaded in Transferrin-Conjugated Liposomes versus Stealth Liposomes against HCT-8 Colon Cancer Cells.
Leto I; Coronnello M; Righeschi C; Bergonzi MC; Mini E; Bilia AR
ChemMedChem; 2016 Aug; 11(16):1745-51. PubMed ID: 26999297
[TBL] [Abstract][Full Text] [Related]
4. A novel redox-sensitive system based on single-walled carbon nanotubes for chemo-photothermal therapy and magnetic resonance imaging.
Hou L; Yang X; Ren J; Wang Y; Zhang H; Feng Q; Shi Y; Shan X; Yuan Y; Zhang Z
Int J Nanomedicine; 2016; 11():607-24. PubMed ID: 26917960
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional mesoporous nanoparticles as pH-responsive Fe(2+) reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth.
Chen J; Guo Z; Wang HB; Zhou JJ; Zhang WJ; Chen QW
Biomaterials; 2014 Aug; 35(24):6498-507. PubMed ID: 24797880
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting.
Prajapati SK; Jain A; Shrivastava C; Jain AK
Int J Biol Macromol; 2019 Feb; 123():691-703. PubMed ID: 30445095
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
8. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.
Emami J; Yousefian H; Sadeghi H
J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis.
Nakase I; Gallis B; Takatani-Nakase T; Oh S; Lacoste E; Singh NP; Goodlett DR; Tanaka S; Futaki S; Lai H; Sasaki T
Cancer Lett; 2009 Feb; 274(2):290-8. PubMed ID: 19006645
[TBL] [Abstract][Full Text] [Related]
10. The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment.
Shi J; Ma R; Wang L; Zhang J; Liu R; Li L; Liu Y; Hou L; Yu X; Gao J; Zhang Z
Int J Nanomedicine; 2013; 8():2361-73. PubMed ID: 23843694
[TBL] [Abstract][Full Text] [Related]
11. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
13. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.
Kim TH; Jo YG; Jiang HH; Lim SM; Youn YS; Lee S; Chen X; Byun Y; Lee KC
J Control Release; 2012 Sep; 162(2):422-8. PubMed ID: 22824780
[TBL] [Abstract][Full Text] [Related]
14. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
16. An Intelligent and Tumor-Responsive Fe
Zhang H; Chen Q; Zhang X; Zhu X; Chen J; Zhang H; Hou L; Zhang Z
ACS Appl Mater Interfaces; 2016 Dec; 8(49):33484-33498. PubMed ID: 27960409
[TBL] [Abstract][Full Text] [Related]
17. LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics.
Wang Z; Yu Y; Ma J; Zhang H; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Mol Pharm; 2012 Sep; 9(9):2646-57. PubMed ID: 22853186
[TBL] [Abstract][Full Text] [Related]
18. Biotin-functionalized copolymeric PEG-PCL micelles for in vivo tumour-targeted delivery of artemisinin.
Nosrati H; Barzegari P; Danafar H; Kheiri Manjili H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):104-114. PubMed ID: 30663422
[TBL] [Abstract][Full Text] [Related]
19. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells.
Sadava D; Phillips T; Lin C; Kane SE
Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669
[TBL] [Abstract][Full Text] [Related]
20. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
